Erin Parsons
Non-Employee Independent DirectorMs. Erin Parsons has been Non-Employee Independent Director of Kiora Pharmaceuticals, Inc., since February 2022. She has been an Director at Alimera Sciences, Inc. since November 30, 2021. Ms. Parsons has experience working in the ophthalmic industry overseeing scientific strategy, medical communications, advocacy development, and peer-to-peer educational programs, much of this in the retina space. Her extensive ophthalmic expertise and retina background brings additional perspectives to its strategic initiatives to increase ILUVIEN advocacy and its engagement with the physician community as we strive to make Alimera the place to be in retina. Ms. Parsons is a respected and highly sought-after ophthalmic industry veteran based in Boston, MA. She has wide-ranging experience in several therapeutic areas in eyecare including nearly every major disease state of the eye. She founded the eyecare-only medical strategy and communications company, Parsons Medical Communications (PMC) in 2010 and serves as its President. She was involved in the launch of LUCENTIS® (Roche/Genentech) and has experience with other retina products and programs including pegcetacoplan, an investigational therapy for geographic atrophy (Apellis); OTT166, an investigational topical integrin inhibitor for diabetic retinopathy (OcuTerra); Encapsulated Cell Therapy for retina disease (Neurotech); ForeseeHome® monitoring device (Notal Vision); antisense oligonucleotide gene therapy (Wave Therapeutics); and BEOVU® and TRIESENCE® for retinal disease (Novartis). She is also involved with various associations in the eyecare space including Ophthalmic World Leaders (OWL), the Ophthalmology Innovation Summit (where she led a Masterclass on KOL Advocacy), and The Holland Foundation for Sight Restoration. Ms. Parsons received a BS in Biology from Wake Forest University.
Positions
- Company NameKiora Pharmaceuticals, Inc.Stock CodeKPRXPositionNon-Employee Independent DirectorColleagues
- BMBrian M. StremPresident, CEO & Director
- PTPraveen TyleIndependent Chairman of the Board
- MTMelissa ToscaChief Financial Officer
- SSStefan SperlExecutive Vice President of CMC & Operations
- KJKeith J. LaneExecutive VP and Head of Clinical Development & Regulatory Affairs
- DADavid A. HollanderIndependent Director
- LWLisa Walters-HoffertIndependent Director
